# Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia

> **NCT06231459** · PHASE4 · COMPLETED · sponsor: **Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado** · enrollment: 20 (actual)

## Conditions studied

- Hypercholesterolemia, Familial

## Interventions

- **DRUG:** Evolocumab

## Key facts

- **NCT ID:** NCT06231459
- **Lead sponsor:** Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06231459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06231459, "Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06231459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*